Edition:
India

Michael Erman

Merck CEO sees legal challenge if U.S. adopts drug pricing based on other countries

21 Jun 2019

NEW YORK Merck & Co Chief Executive Ken Frazier said on Thursday a rule to base the price the U.S. government pays for some prescription drugs in it Medicare program on lower prices in other countries would face legal challenges if adopted.

Pfizer makes $10.6 billion cancer bet in cash deal for Array Biopharma

18 Jun 2019

Pfizer Inc said on Monday it would buy Array Biopharma Inc for $10.64 billion in cash, a deal it hopes will help make it a leader in colon cancer and build up its pipeline of oncology drugs.

FDA approves Lilly's migraine drug as first ever cluster headache treatment

05 Jun 2019

NEW YORK Eli Lilly and Co's migraine treatment Emgality on Tuesday became the first drug to gain U.S. approval for decreasing the frequency of episodic cluster headache attacks, the Food and Drug Administration said https://reut.rs/2QMtzVE.

NHS England, Biogen reach deal on pricey drug for deadly disorder

15 May 2019

NEW YORK England's National Health Service said it had reached a deal to pay for U.S. drugmaker Biogen Inc's expensive spinal muscle atrophy treatment Spinraza.

NHS England, Biogen reach deal on pricey drug for deadly disorder

15 May 2019

NEW YORK England's National Health Service said it had reached a deal to pay for U.S. drugmaker Biogen Inc's expensive spinal muscle atrophy treatment Spinraza.

NHS England, Biogen reach deal on pricey drug for deadly disorder

15 May 2019

NEW YORK, May 14 England's National Health Service said it had reached a deal to pay for U.S. drugmaker Biogen Inc's expensive spinal muscle atrophy treatment Spinraza.

U.S. government to require drugmakers to show prices in TV ads

08 May 2019

The Trump administration on Wednesday said it will require drugmakers to disclose the list price of prescription drugs in direct-to-consumer television advertisements, part of the government's efforts to lower costs for U.S. consumers.

Pfizer gets U.S. approval for $225,000 a year heart drug

06 May 2019

NEW YORK The U.S. Food and Drug Administration on Monday approved Pfizer Inc's oral drug, tafamidis, to treat a rare and fatal heart disease called transthyretin amyloid cardiomyopathy, the U.S drugmaker said.

Merck steps up U.S. measles vaccine production with increased demand

02 May 2019

NEW YORK Merck & Co said on Wednesday it has increased production of the measles vaccine to meet an uptick in demand in the United States in the midst of the country's biggest outbreak in 25 years.

World News